Woodline Partners LP Tg Therapeutics, Inc. Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 2,565,322 shares of TGTX stock, worth $82.6 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

2,565,322

Previous 1,419,534 80.72%

Holding current value

$82.6 Million

Previous $25.3 Million 137.6%

% of portfolio

0.54%

Previous 0.25%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $19.7 Million - $29 Million	1,145,788 Added 80.72%	2,565,322 $60 Million
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $198,960 - $286,641	14,937 Added 1.06%	1,419,534 $25.3 Million
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $4.74 Million - $7.75 Million	-363,837 Reduced 20.57%	1,404,597 $21.4 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $10.8 Million - $30.4 Million	1,616,295 Added 1062.38%	1,768,434 $30.2 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $88,942 - $281,933	10,639 Added 7.52%	152,139 $1.27 Million
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $2.19 Million - $4.95 Million	141,500 New	141,500 $3.51 Million
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $8.15 Million - $19.3 Million	1,627,664 Added 174.19%	2,562,100 $30.3 Million
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $4.27 Million - $7.85 Million	934,436 New	934,436 $5.53 Million
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $1.63 Million - $3.8 Million	-106,932 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $107,854 - $200,308	4,952 Added 4.86%	106,932 $3.56 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $26.8 Million - $40.4 Million	-824,786 Reduced 89.0%	101,980 $3.96 Million
Q1 2021 May 17, 2021	BUY	$41.61 - $54.3 $37.2 Million - $48.5 Million	893,514 Added 2687.1%	926,766 $44.7 Million
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $4.21 Million - $9.15 Million	-166,623 Reduced 83.36%	33,252 $1.73 Million
Q3 2020 Nov 16, 2020	SELL	$18.49 - $27.24 $2.46 Million - $3.62 Million	-132,777 Reduced 39.91%	199,875 $5.35 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $2.96 Million - $7.27 Million	332,652 New	332,652 $6.48 Million

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.68B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Tg Therapeutics, Inc. Transaction History